Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» AKT inhibitors
AKT inhibitors
Roche Abandons AKT Prostate Cancer Asset
Roche Abandons AKT Prostate Cancer Asset
BioSpace
Roche
AKT inhibitors
Ipatasertib
clinical trials
castration-resistant prostate cancer
prostate cancer
Flag link:
Backed by Medicxi, Novartis vets launch rare blood disorder biotech with fresh take on drug class used in cancers
Backed by Medicxi, Novartis vets launch rare blood disorder biotech with fresh take on drug class used in cancers
Endpoints
Novartis
AKT inhibitors
Vaderis Therapeutics
Medicxi
Flag link:
